Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update

Go back to Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
(NASDAQ: CRDF) Delayed: 1.02 +0.14 (15.91%)
Previous Close $0.88    52 Week High
Open $0.94    52 Week Low
Day High $1.05    P/E N/A 
Day Low $0.93    EPS
Volume 1,096,734